DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE REACTION INTERACTIONS NURSING

IMPLEMENTATION

Generic Name: Paracetamol Treatment of There is a paucity of . Use undiluted

has both short term, trials in neonates and as
Paracetamol Vomiting, fever, rash, Caution if taken
analgesic and mild to a result the safety and
300mg IV neutropoenia, concomitantly with
antipyretic moderate pain efficacy in preterm Keep in cool, dry place,
leucopoenia, barbiturates,
actions. It and/or fever infants is not protected from light in <
thrombocytopenia. May anticoagulants,
inhibits when enteral established. 30o C. Do not refrigerate.
Brand Name: cause liver toxicity at high zidovudine, amoxicillin
prostoglandin route not Discard
plasma levels. (Medsafe -last updated
Tylenol biosynthesis. available or vial immediately after use.
Therapeutic levels are 10- Oct 2008)
Its half-life is contraindicated
Class: 30 mg/L Monitor liver and renal
approximately (Anderson Compatible with normal
3.5 hours. 2005) function. Plasma half-life
Analgesic and saline
in neonates is
antipyretic approximately 3.5 hours
in term (Anaesthesia UK -
FRCA) and up to 11hours
in preterm infants and it is
excreted mainly as
glucuronide and sulphate
conjugates (Medsafe
2008, RHW).

Unconjugated
hyperbilirubinaemia
impacts on clearance
necessitating a dose
reduction (Palmer 2008).
Drug of choice for
overdose is regimen of N-
acetylcysteine IV infusion.
DRUG NAME ACTION INDICATIONS CONTRAINDICATI ADVERSE REACTION INTERACTIONS NURSING
ON IMPLEMENTATI
ON

Generic  . Blocks  Hypertensi Contraindicated CNS: dizziness, fatigue, weakness,  General anesthetics, IV  Monitor BP
Name: in: anxiety, depression, drowsiness,
stimulation on. phenytoin, diltiazem, and pulse
 History of insomnia, memory loss, mental
Carvedilol of  HF status changes, nervousness, and verapamil may cause ↑ frequently
serious
beta1(myoc (ischemic nightmares myocardial depression. during dose
Brand Name: hypersensitivity
ardial) and or EENT: blurred vision, dry eyes,  ↑ risk of bradycardia adjustment
reaction intraoperative floppy iris syndrome,
Coreg beta2 (pulm cardiomyo with digoxin. period and
(Stevens- nasal stuffiness
Coreg CR onary, pathic) with Resp: bronchospasm, wheezing  Amiodarone or fluconazole periodically
Johnson
vascular, digoxin, CV: BRADYCARDIA, HF, PULMON may ↑ levels. during
syndrome,
Class: and diuretics, ARY EDEMA  ↑ hypotension may occur therapy. Asses
angioedema, GI: diarrhea, constipation, nausea
uterine)- and ACE with s for
antihypertensiv anaphylaxis); GU: erectile dysfunction, ↓ libido
adrenergic inhibitors. Derm: STEVENS-JOHNSON other antihypertensives, orthostatic
es  Pulmonary
beta blockers receptor  Left SYNDROME, TOXIC EPIDERMAL acute ingestion of alcohol, hypotension
edema; NECROLYSIS, itching, rashes,
sites. ventricular or nitrates. when assisting
 Cardiogenic urticaria
 Also has dysfunction  Concurrent use patient up
shock; Endo: hyperglycemia,
alpha1 bloc after with clonidine ↑ hypotension from supine
 Bradycardia, hypoglycemia
king myocardial MS: arthralgia, back pain, muscle and bradycardia. position.
heart block or
activity, infarction. cramps  May ↑ withdrawal  Monitor intake
sick sinus Neuro: paresthesia
which may phenomenon and output
syndrome Misc: ANAPHYLAXIS, ANGIOEDE
result in from clonidine (discontinue ratios and
(unless a MA, drug-induced lupus syndrome
orthostatic carvedilol first). daily weight.
pacemaker is in
hypotensio  Concurrent administration Assess patient
place);
n. of thyroid routinely for
 Therapeutic  Uncompensated preparations may ↓ evidence of
Effect(s):
HF requiring IV effectiveness. fluid overload
 Decreased
inotropic agents  May alter the effectiveness (peripheral
heart rate
(wean before of insulins or oral edema,
and BP.
starting hypoglycemic dyspnea,
 Improved
carvedilol); agents (dose adjustments rales/crackles,
cardiac
 Severe hepatic may be necessary). fatigue, weight
output,
impairment;  May ↓ effectiveness gain, jugular
slowing of
 Asthma or other of theophylline. venous
the
bronchospastic  May ↓ beneficial beta1- distention).
progression
disorders. cardiovascular effects Patients may
of HF and
of dopamine or dobutamin experience
decreased
e. worsening of
risk of
 Use cautiously within 14 symptoms
death.
days of MAO during
inhibitor therapy (may result initiation of
in hypotension/bradycardia). therapy for
 Cimetidine may ↑ toxicity HF.
from carvedilol. Do not confuse
 Concurrent NSAIDs may ↓ carvedilol with
captopril
antihypertensive action.
 Effectiveness may be ↓ PO: Take apical
by rifampin. pulse before
 May ↑ serum digoxin levels. administering. If
<50 bpm or if
 May ↑ blood levels
arrhythmia
of cyclosporine (monitor occurs, withhold
blood levels). medication and
notify health care
professional.
Instruct patient to
take medication
as directed, at the
same time each
day, even if
feeling well. Do
not skip or double
up on missed
doses. Take
missed doses as
soon as possible
up to 4 hr before
next dose. Abrupt
withdrawal may
precipitate life-
threatening
arrhythmias,
hypertension, or
myocardial
ischemia.
Advise patient to
notify health care
professional if
slow pulse,
difficulty
breathing,
wheezing, cold
hands and feet,
dizziness,
confusion,
depression, rash,
fever, sore throat,
unusual bleeding,
 or bruising
occurs.

DRUG NAME ACTION INDICATIONS CONTRAINDICAT ADVERSE INTERACTION NURSING

ION REACTION S IMPLEMENTATI
ON

Generic Name: Contains treat and prevent symptoms Hypersensitivity to Lung . Avoid MAOIs, Not for primary
2 medications: ipratropium and albuter (wheezing and shortness of albuterol, disorders, tricyclics within treatment of
Salbutamol(albuter ol (also known as salbutamol). Both breath) caused by ipratropium, pharyngitis, 14 days acute attack.
ol)+ Ipratropium drugs work by relaxing the muscles ongoing lung disease (chronic atropine and chest pain, (increased Avoid excessive
inhalation around the airways so that they open obstructive pulmonary derivatives, soy, or GI cardiovascular use. Discontinue
up and you can breathe more easily. disease-COPD which peanut disturbances effects). if paradoxical
Brand Name: Controlling symptoms of breathing
includes bronchitis and emphy , bronchitis, Caution with bronchospasm
Duoneb problems can decrease time lost from
sema) UTI, leg other or cardiovascular
work or school.
Class: cramps, anticholinergics, effects occur.
pain, voice sympathomimet
Anticholinergic Nursing mothers:
changes, ics, drugs that
not
anticholinerg lower
Beta- agonist recommended
ic effects, potassium.
nervousness Monitor digoxin.
, headache, Antagonized by
dizziness, β-blockers.
 insomnia,
tachycardia,
hypokalemia
, paradoxical
bronchospas
m.

DRUG ACTION INDICATIO CONTRAINDICATI ADVERSE INTERACTIONS NURSING

NAME NS ON REACTION IMPLEMENTATIO
N

Generic  Severe Contraindicated  . Use with extreme caution in patients Assess level of
Name: . Binds to opiate in: consciousness,
receptors in the pain (the CNS: confusion, sedat receiving MAO inhibitors within 14 days prior
 Hypersensitivity; BP, pulse, and
Morphine CNS. Alters the 20 ion, dizziness, (may result in unpredictable, severe
 Some products respirations before
perception of mg/mL dysphoria, euphoria, reactions–↓ initial dose of morphine to 25% of
Brand and response to contain floating feeling, and periodically
Name: oral usual dose). during
painful stimuli tartrazine, hallucinations,
while producing solution headache, unusual  Use with benzodiazepines or other CNS administration. If
 Arymo bisulfites, or respiratory rate is
generalized concentr dreams depressants including otheropioids, non-
ER CNS alcohol and EENT: blurred vision, <10/min, assess
ation benzodiazepine
 Astramor depression. should be diplopia, miosis level of sedation.
should sedative/hypnotics, anxiolytics, general
Therapeutic avoided in Resp: RESPIRATOR Physical
ph only be anesthetics, muscle
Effect(s): patients with Y DEPRESSION stimulation may be
Decrease in used in CV: hypotension, relaxants, antipsychotics, and alcohol may sufficient to
severity of pain. known bradycardia
opioid- cause profound sedation, respiratory prevent significant
Addition of hypersensitivity; Endo: adrenal
tolerant depression, coma, and death; reserve hypoventilation.
Class: naltrexone  Acute, mild, insufficiency
Subsequent doses
in Embeda prod patients). GI: constipation, concurrent use for when alternative treatment
intermittent, or may need to be
opioid uct is designed  Pain nausea, vomiting options are inadequate.
analgesics postoperative GU: urinary retention  decreased by 25–
to prevent severe Drugs that affect serotonergic
abuse or pain Derm: flushing, 50%. Initial
enough neurotransmitter systems, including tricyclic
misuse by (extended/sustai itching, sweating drowsiness will
to require antidepressants, SSRIs, SNRIs, MAO
altering the daily, ned-release); Misc: physical inhibitors, TCAs, tramadol, trazodone, mirt diminish with
formulation. dependence, continued use.
around-  Significant azapine, 5–HT3 receptor
Naltrexone has psychological
no effect unless the-clock respiratory dependence, antagonists, linezolid, methylene blue, Assess risk for
the capsule is long-term depression tolerance and triptans ↑ risk of serotonin syndrome. opioid addiction,
crushed or opioid (extended-  Administration of partial-antagonist opioid abuse, or misuse
chewed. treatment release); analgesics may precipitate opioid withdrawal prior to
administration.
and for  Acute or severe in physically dependent patients.
Abuse or misuse
which bronchial  Buprenorphine, nalbuphine, butorphanol, of extended-
alternativ asthma or pentazocine may ↓ analgesia. release
e (extended-  May ↑ the anticoagulant effect of warfarin. preparations by
treatment release);  Cimetidine ↓ metabolism and may ↑ effects. crushing, chewing,
options  Paralytic ileus snorting, or
are (extended- injecting dissolved
product will result
inadequa release).
in uncontrolled
te delivery of
(extende morphine and can
d- result in overdose
release). and death.
 Pulmona
 Do not confuse
ry
MS Contin
edema.
(morphine
 Pain
sulfate) with
associate
Oxycontin
d with
(oxycodone).
MI.
Do not confuse
morphine (non-
concentrated
oral liquid) with
morphine
 (concentrated
oral liquid).
 High Alert: Do
not confuse
morphine with
hydromorphone
–errors have
resulted in
death.
Administer 2.5–15
mg over 5 min.
Rapid
administration
may lead to
increased
respiratory
depression,
hypotension, and
circulatory
collapse.
Explain to patient
and family how
and when to
administer
morphine and how
to care for infusion
equipment
properly. Pedi: Te
ach parents or
caregivers how to
accurately
measure liquid
 medication and to
use only the
measuring device
dispensed with the
medication

DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE REACTION INTERACTIONS NURSING

IMPLEMENTATION

Generic Name: . .

Brand Name:

Class:

DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE REACTION INTERACTIONS NURSING

IMPLEMENTATIO
N

Generic Name:  Alone or Contraindicated in: CNS: dizziness, fatigue,  . Concurrent use Assess patient for
. Angiotensin- headache, insomnia
with other  Hypersensitivity with sacubitril ↑ risk of signs of
Captopril converting Resp: cough angioedema
Brand Name: enzyme (ACE) agents in  History of CV: hypotension, chest pain, angioedema; concurrent (swelling of face,
inhibitors block palpitations, tachycardia extremities, eyes,
Capoten the angioedema with use contraindicated; do
the conversion GI: taste disturbances, lips, tongue,
of angiotensin manageme previous use of ACE abdominal pain, anorexia, not administer within 36
Class: difficulty in
I to the nt of inhibitors constipation, diarrhea, hr of switching swallowing or
antihypertensive vasoconstricto hypertensio  Concurrent use with nausea, vomiting to/from sacubitril/valsart breathing); may
s r angiotensin n. aliskiren in patients GU: proteinuria, impaired an. occur at any time
II. ACE renal function
inhibitors also  
Manageme with diabetes or Derm: ANGIOEDEMA, rash, Excessive hypotension during therapy.
ace inhibitors
prevent the nt of heart moderate-to-severe pruritis may occur with Discontinue
degradation of failure. renal impairment F and E: hyperkalemia concurrent use medication and
bradykinin and  Hemat: AGRANULOCYTOSI provide supportive
Reduction (CCr <60 mL/min); of diuretics.
other S, neutropenia care.
of risk of  Concurrent use with  Additive hypotension with
vasodilatory Misc: fever
prostaglandins death, heart sacubitril/valsartan; other antihypertensives. Monitor CBC with
. ACE failure- must be a 36–hr  ↑ risk of hyperkalemia differential prior to
inhibitors also initiation of therapy,
related washout period after with concurrent use
↑ plasma renin every 2 wk for the
hospitalizati switching to/from ofpotassium
levels and ↓ first 3 mo, and
aldosterone ons, and sacubitril/valsartan; supplements, potassiu periodically for up
levels. Net developme  OB: Can cause injury m-sparing diuretics, to 1 yr in patients at
result is nt of overt or death of fetus – if or potassium-containing risk for neutropenia
systemic heart failure pregnancy occurs, salt substitutes. (patients with renal
vasodilation. impairment, or
Therapeutic following discontinue  ↑ risk of hyperkalemia,
collagen-vascular
Effect(s): myocardial immediately renal dysfunction,
disease) or at first
 Lowering of infarction.  Lactation: Discontinu hypotension, and sign of infection.
BP in  Treatment e drug or use syncope with concurrent Discontinue
patients of diabetic formula. use of angiotensin II therapy if
with nephropath receptor neutrophil count is
hypertensio y in patients blockers or aliskiren; <1000/mm3.
n. with Type 1 avoid concurrent use with Do not confuse
 Improved diabetes aliskiren in patients with captopril with
survival mellitus and diabetes or CCr <60 carvedilol.
 and retinopathy. mL/min; avoid concurrent Instruct patient to
reduced use with angiotensin II notify health care
professional if
symptoms receptor blockers.
immediately rash;
in patients  NSAIDs and mouth sores; sore
with heart selective COX-2 throat; fever;
failure. inhibitors may blunt the swelling of hands
 Improved antihypertensive effect or feet; irregular
survival and ↑ the risk of renal heart beat; chest
and dysfunction. pain; dry cough;
hoarseness;
reduced  ↑ levels and may ↑ the
swelling of face,
developme risk of lithium toxicity. eyes, lips, or
nt of overt  ↑ risk of angioedema tongue; difficulty
heart with temsirolimus, siroli swallowing or
failure after mus, or everolimus. breathing occurs;
myocardial Drug-Natural Products: or if taste
infarction. impairment or skin
Avoid natural licorice
rash persists
 Decreased (causes sodium and water
progression retention and increases
potassium loss).
of diabetic
Drug-Food:
nephropath
y with Food significantly ↓
absorption. Administer
decreased
captopril 1 hr before meals.
need for
transplantat
ion or
dialysis.
DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE INTERACTIONS NURSING
REACTION IMPLEMENTATION

Generic Name: Maintain acid- low potassium Contraindicated in: CNS: confusion, Drug-Drug: Use with asess for signs and
base balance, (hypokalemia) Hyperkalemia; Severe restlessness, potassium-sparing symptoms of
Potassium Chloride Increase effect
isotonicity, and renal impairment; weakness. CV: diuretics or hypokalemia
Brand Name: electrophysiologic of another Untreated Addison’s ARRHYTHMIAS, ACEinhibitors or (weakness, fatigue, U
balance of the treatment disease; Some ECG changes. GI: angiotensin II wave on ECG,
 Neo-K cell. Activator in General health products may contain abdominal pain, receptor antagonists arrhythmias, polyuria,
 Potassium Sandoz many enzymatic
stiffness/spasticity
tartrazine (FDC yellow diarrhea, flatulence, may lead to polydipsia) and
reactions; dye #5) or alcohol; nausea, hyperkalemia. hyperkalemia
Treat side
essential to vomitingtablets, Anticholinergics
Class: effects of another avoid using in patients Administer with or after
transmission of capsules only, GI mayqGI mucosal
treatment with known meals to decrease GI
mineral and electrolyte nerve impulses; ulceration, stenotic lesions in patients
hypersensitivity or irritation.
replacements/supplements contraction of intolerance;
lesions.Neuro: taking wax-matrix
cardiac, skeletal, paralysis, potassium chloride Explain to patient
Hyperkalemic familial
and smooth paresthesia. preparations. purpose of the
periodic paralysis. Use
muscle; gastric Interactions Drug- medication and the
Cautiously in: Cardiac
secretion; renal Drug: Use with need to take as
disease; Renal
function; tissue potassium-sparing directed, especially
impairment; Diabetes
synthesis; and diuretics or when concurrent
mellitus (liquids may
carbohydrate ACEinhibitors or digoxin or diuretics are
contain sugar);
metabolism. angiotensin II taken. A missed dose
Hypomagnesemia
Therapeutic receptor antagonists should be taken as
(may make correction
Effects: may lead to soon as remembered
of hypokalemia more
Replacement. hyperkalemia. within 2 hr; if not,
difficult); GI
Prevention of Anticholinergics return to regular dose
hypomotility including
deficiency mayqGI mucosal schedule. Do not
dysphagia or
lesions in patients double dose.
esophageal
taking wax-matrix
compression from left Emphasize the
potassium chloride
atrial enlargement importance of regular
preparations.
(tablets, capsules); follow-up exams to
Route/Dosage
Patients receiving monitor serum levels
Expressed as mEq
potassium-sparing
drugs. of potassium. and progress.
Potassium
bicarbonate contains
10 mEq potassium/
g; potassium chloride
contains 13.4 mEq
potassium/g. Normal
Daily Requirements
PO (Adults): 40– 80
mEq/day. PO
(Children): 2– 3
mEq/kg/day. PO
(Neonates): 2– 6
mEq/kg/day.
Prevention of
hypokalemia during
Diuretic Therapy PO
(Adults): 20– 40
mEq/day in 1– 2
divided doses; single
dose should not
exceed 20 mEq. PO
(Neonates , Infants
and Children): 1– 2
mEq/kg/day in 1– 2
divided doses.
Treatment of
Hypokalemia PO
(Adults): 40– 100
mEq/day in divided
doses. PO
(Neonates , Infants
and Children): 2– 5
mEq/kg/day in
 divided doses

DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE REACTION INTERACTIONS NURSING

IMPLEMENTATION

Generic Name: . Trimetazidine Trimetazidine Parkinson's disease, Dizziness, headache, Use with extreme Instruct patient to take
inhibits β- is used in parkinsonian symptoms, abdominal pain, caution in patients Trimetazidine with food
Trimetazidine
oxidation of combination tremors, restless leg dyspepsia, diarrhoea, and do not take in larger
receiving MAO
fatty acids with other syndrome and other nausea, vomiting, amounts than
through drugs for the movement related pruritus, rash, urticaria, inhibitors within 14 advised/prescribed.
Brand Name: inhibition of symptomatic disorders. Severe renal asthenia. Rarely, days prior (may result in Advised patient to report
long-chain 3- treatment of impairment (CrCl <30 tachycardia, palpitations, unpredictable, severe any undesirable side
Metacart
ketoacyl-CoA stable angina mL/min). Lactation. extrasystoles, orthostatic reactions–↓ initial dose effects.
Trimet thiolase, which pectoris, chest hypotension, arterial of morphine to 25% of Ensure that the treatment
enhances pain caused by hypotension, flushing. usual dose).
Class: course is completed.
glucose decreased
Anti-Anginal Drugs oxidation. It oxygen supply Instruct patient to not stop
ensures proper due to reduced the use of this medicine
functioning of blood flow to without consulting her
ionic pumps the heart. This doctor.
and medicine is
transmembrane used when
Na-K flow by patients do not
preventing respond
decrease in adequately to
intracellular other agents or
ATP levels. are intolerant
to first line anti-
anginal agents.
DRUG ACTION INDICATI CONTRAINDICA ADVERSE REACTION INTERACTIONS NURSING
NAME ONS TION IMPLEMENTATION

Generic  Inhibit  Edema Contraindicated CNS: blurred vision, dizziness,  . ↑ risk of hypotension Assess patient for skin
Name: in: headache, vertigo
s the due to with antihypertensives, nitrates, or rash frequently during
 Hypersensitivit EENT: hearing loss, tinnitus therapy. Discontinue
Furosem reabs heart CV: hypotension acute ingestion of alcohol.
y; furosemide at first sign of
ide orptio failure, GI: anorexia, constipation, diarrhea,  ↑ risk of hypokalemia with rash; may be life-
 Cross- dry mouth, dyspepsia, ↑ liver
Brand n of hepatic other diuretics, amphotericin threatening. Stevens-
sensitivity with enzymes, nausea, pancreatitis,
Name: sodiu impairm B, stimulant laxatives, Johnson syndrome, toxic
thiazides and vomiting
m ent, or GU: ↑ BUN, excessive urination, and corticosteroids. epidermal necrolysis, or
Lasix sulfonamides erythema multiforme may
and renal nephrocalcinosis  Hypokalemia may ↑ risk
may occur; develop. Treat
Class: chlori disease. Derm: ERYTHEMA of digoxin toxicity and ↑ risk of
 Hepatic coma MULTIFORME, STEVENS- symptomatically; may
de  Hyperte arrhythmia in patients taking drugs
Loop or anuria; JOHNSON SYNDROME, TOXIC recur once treatment is
diuretics from nsion. EPIDERMAL NECROLYSIS, that prolong the QT interval. stopped.
 Some liquid
the photosensitivity, pruritis, rash,  ↓ lithium excretion, may
products may urticaria  Do not confuse Lasix
loop cause lithium toxicity.
contain Endo: hypercholesterolemia,
of  ↑ risk of ototoxicity with Luvox.
alcohol, avoid hyperglycemia, hypertriglyceridemia, o If administering
Henle with aminoglycosides or cisplatin.
in patients hyperuricemia
and F and  ↑ risk of nephrotoxicity twice daily, give last
with alcohol dose no later than
distal E: dehydration, hypocalcemia, hypoc with cisplatin.
intolerance. hloremia, hypokalemia, hypomagnes
renal  NSAIDS ↓ effects of furosemide. 5 PM to minimize
Use Cautiously emia, hyponatremia, hypovolemia, m
tubule in:  May ↑ risk of methotrexate toxicity. disruption of sleep
etabolic alkalosis
.  Severe liver Hemat: APLASTIC  ↓ effects of furosemide when given cycle.
 Incre ANEMIA, AGRANULOCYTOSIS, at same time o IV route is preferred
disease (may
ases hemolytic anemia, leukopenia, as sucralfate, cholestyramine, over IM route for
precipitate
renal thrombocytopenia or colestipol. parenteral
hepatic coma; MS: muscle cramps
excret concurrent  ↑ risk of salicylate toxicity (with use administration.
Neuro: paresthesia
ion of Misc: fever of high-dose salicylate therapy).  PO: May be taken with
use with
water, potassium-  Concurrent use food or milk to
 sodiu sparing with cyclosporine may ↑ risk of minimize gastric
m, diuretics may gouty arthritis. irritation. Tablets may
chlori be necessary); be crushed if patient
de,  Electrolyte has difficulty
magn depletion; swallowing
esium  Diabetes Advise patient to contact
, mellitus; health care professional
immediately if rash,
potas  Hypoproteine
muscle weakness,
sium, mia (↑ risk of cramps, nausea,
and ototoxicity); dizziness, numbness, or
calciu  Severe renal tingling of extremities
m. impairment (↑ occurs.
 Effect risk of
ivene ototoxicity);
ss
persis
ts in
impair
ed
renal
functi
on.
Therape
utic
Effect(s)
:
 Diure
sis
and
subse
 quent
mobili
zation
of
exces
s fluid
(ede
ma,
pleur
al
effusi
ons).
 Decre
ased
BP.

DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE INTERACTIONS NURSING

REACTION IMPLEMENTATION
Generic Name: . Produce Inflammatory Contraindicated in: EENT: tinnitus. GI: GI . Drug-Drug: Mayqthe Patients who have
analgesia and disorders Hypersensitivity to BLEEDING, risk of bleeding with asthma, allergies,
Aspirin
reduce including: aspirin or other dyspepsia, epigastric warfarin, heparin, and nasal polyps or
Brand Name: inflammation Rheumatoid salicylates; Cross- distress, nausea, heparin-like agents, who are allergic to
and fever by arthritis, sensitivity with other abdominal pain, thrombolytic agents, tartrazine are at an
acetylsalicylic acid, inhibiting the Osteoarthritis.Mild NSAIDs may exist anorexia, dipyridamole, increased risk for
Acuprin, ASA, Asaphen, production of tomoderate pain. (less with nonaspirin hepatotoxicity, ticlopidine,clopidogrel, developing
Aspergum, Aspir-Low, prostaglandins. Fever. salicylates); Bleeding vomiting. Hemat: tirofiban, or eptifibatide, hypersensitivity
Aspirtab, Bayer Aspirin, Decreases Prophylaxis of disorders or anemia, hemolysis. although these agents reactions.
Class: platelet transient ischemic thrombocytopenia; Derm: rash, are frequently used Use lowest effective
aggregation. attacks and MI. Pedi: May increase urticaria.Misc:allergic safely in combination dose for shortest
antipyretics, nonopioid
Therapeutic Unlabeled Use: risk of Reye’s reactions including and in sequence. period of time. ● PO:
analgesics
Effects: Adjunctive syndrome in children ANAPHYLAXISand Ibuprofen: may negate Administer after
Pharmacologic:salicylates
Analgesia. treatment of or adolescents with LARYNGEAL the cardioprotective meals or with food or
Reduction of Kawasaki viral infections. Use EDEMA. antiplatelet effects of an antacid to
inflammation. disease. Cautiously in: History low-dose aspirin. minimize gastric
Reduction of of GI bleeding or ulcer Mayqrisk of bleeding irritation. Food slows
fever. disease; Chronic with but does not alter the
Decreased alcohol use/ abuse; cefoperazone,cefotetan, total amount
incidence of Severe hepatic or and valproic acid. absorbed.
transient renal disease; OB: Mayqactivity of
Caution patient to
ischemic Salicylates may have penicillins, phenytoin,
avoid concurrent use
attacks and MI. adverse effects on methotrexate,valproic
of alcohol with this
fetus and mother and acid, oral hypoglycemic
medication to
should be avoided agents, and
minimize possible
during pregnancy, sulfonamides. Urinary
gastric irritation; 3 or
especially during the acidificationq
more glasses of
3rd trimester; reabsorption and
alcohol per day may
Lactation:Safety not mayqserum salicylate
increase risk of GI
established; Geri:qrisk levels. Alkalinization of
bleeding. Caution
of adverse reactions the urine or the
patient to avoid taking
especially GI bleeding; ingestion of large
concurrently with
more sensitive to toxic amounts of
acetaminophen or
levels. antacidsqexcretion
NSAIDs for more
andpserum salicylate
than a few days,
levels. May blunt the
unless directed by
therapeutic response to
health care
diureticsand ACE
professional to
inhibitors.qrisk of GI
prevent analgesic
irritation with NSAIDs.
nephropathy.
Drug-Natural
Products:qanticoagulant
effect and bleeding risk
 with arnica, chamomile,
clove, feverfew, garlic,
ginger, ginkgo, Panax
ginseng, and others.
Drug-Food: Foods
capable of acidifying the
urine mayqserum
salicylate levels

DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE REACTION INTERACTIONS NURSING

IMPLEMENTATION
Generic Name: . Inhibits Reduction of Contraindicated in: . Drug-Drug: Concurrent Monitor patient for signs
platelet atherosclerotic Hypersensitivity; abciximab, eptifibatide, of thrombotic
Clopidogrel Incidence of adverse
aggregation by events (MI, Pathologic bleeding tirofiban, aspirin, thrombocytic purpura
reactions similar to that of
Brand Name: irreversibly stroke, (peptic ulcer, NSAIDs, heparin, (thrombocytopenia,
aspirin CNS: depression,
inhibiting the vascular intracranial LMWHs, thrombolytic microangiopathic
Plavix dizziness, fatigue,
binding of ATP death) in hemorrhage); agents, ticlopidine, or hemolytic anemia,
headache. EENT:
Class: to platelet patients at risk Concurrent use of warfarin mayqrisk of neurologic findings, renal
epistaxis. Resp: cough,
receptors. for such events omeprazole or bleeding. dysfunction, fever). May
antiplatelet agents dyspnea, eosinophilic
Therapeutic including esomeprazole; Impaired Maypmetabolism rarely occur, even after
Pharmacologic: pneumonia. CV: chest
Effects: recent MI, CYP2C19 function due andqeffects of short exposure (2 wk).
platelet pain, edema,
Decreased acute coronary to genetic variation; phenytoin, tolbutamide, Requires prompt
hypertension. GI: GI
aggregation occurrence of syndrome Lactation:Lactation. tamoxifen, torsemide, treatment. ● Lab Test
inhibitors BLEEDING, abdominal
atherosclerotic (unstable fluvastatin, and many Considerations: Monitor
pain, diarrhea, dyspepsia,
events in angina/non– NSAIDs. Concurrent bleeding time during
gastritis. Derm: DRUG
patients at risk. Q-wave MI), use with the CYP2C19 therapy. Prolonged
RASH WITH
stroke, or inhibitors, omeprazole bleeding time, which is
EOSINOPHILIA AND
peripheral or esomeprazole time- and dose-
SYSTEMIC SYMPTOMS,
vascular maypantiplatelet effects; dependent, is expected. ●
pruritus, purpura, rash.
disease. avoid concurrent use; Monitor CBC with
Hemat: BLEEDING,
 NEUTROPENIA,
THROMBOTIC
THROMBOCYTOPENIC
PURPURA. Metab:
hypercholesterolemia.
MS: arthralgia, back
pain.Misc: fever,
hypersensitivity reactions.
may consider using H2 differential and platelet
antagonist or another count periodically during
proton pump inhibitor therapy. Neutropenia and
(e.g. dexlansoprazole, thrombocytopenia may
lansoprazole, or rarely occur.
pantoprazole). Drug-
Do not confuse Plavix
Natural
with Paxil. ● Discontinue
Products:qbleeding risk
clopidogrel 5– 7 days
with anise, arnica,
before planned surgical
chamomile, clove,
procedures. If clopidogrel
fenugreek, feverfew,
must be temporarily
garlic, ginger, ginkgo,
discontinued, restart as
Panax ginseng, and
soon as possible.
others.
Premature discontinuation
of therapy may increase
risk of cardiovascular
events.
Advise patient to notify
health care professional
promptly if fever, chills,
sore throat, rash, or
unusual bleeding or
bruising occurs.

DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE INTERACTIONS NURSING

REACTION IMPLEMENTATION

Generic Name: . It suppresses Treatment in Known hypersensitivity Adults: Most common . Atazanavir and Give medication before
stomach acid adults of to any component of adverse reactions in nelfinavir: PRILOSEC meals, preferably in the
omeprazole
secretion by specific duodenal ulcer the formulation or adults (incidence ≥ reduces plasma levels morning for once-daily
Brand Name: inhibition of the H+/K+- (1.1) and gastric substituted 2%) are • Headache, of atazanavir and dosing. If necessary,
ATPase system found ulcer (1.2) • benzimidazoles abdominal pain, nelfinavir. also give an antacid, as
PRILOSEC
at the secretory Treatment in (angioedema and nausea, diarrhea, Concomitant use is prescribed.
Class: surface of gastric adults and anaphylaxis have vomiting, and not recommended
If needed, open capsule
parietal cells. ... The children of occurred) flatulence (6) Pediatric (7.1) • Saquinavir:
proton pump and sprinkle the
inhibitory effect gastroesophageal patients (1 to 16 years PRILOSEC increases
inhibitor of omeprazole occurs granules on applesauce
reflux disease of age): Safety profile plasma levels of
or yogurt or mix with
within 1 hour after oral (GERD) (1.3) and similar to that in saquinavir. Monitor for
water or acidic fruit
administration. maintenance of adults, except that toxicity and consider
juice, such as apple or
healing of erosive respiratory system dose reduction of
cranberry juice. Give
esophagitis events and fever were saquinavir (7.1) • May
immediately.
the most frequently interfere with drugs for
•To give drug via NG
reported reactions in which gastric pH
tube, mix granules in
pediatric studies affects bioavailability
acidic juice because
(e.g., ketoconazole,
enteric coating dissolves
iron salts, ampicillin
in alkaline pH.
esters, and digoxin).
•Because drug can
Patients treated with
interfere with
PRILOSEC and
absorption of vitamin
digoxin may need to
B12, monitor for anemia.
be monitored for
•Be aware that long-
increases in digoxin
term use of medication
toxicity (7.2) • Co-
may increase the risk of
administration of
gastric carcinoma.
clopidogrel with 80 mg
omeprazole may
reduce the
pharmacological
activity of clopidogrel if
given concomitantly or
if given 12 hours apart
(7) • Cilostazol:
PRILOSEC increases
systemic exposure of
cilostazol and one of
its active metabolites.
Consider dose
reduction of
cilostazol.(7.3) • Drugs
metabolized by
cytochrome P450
(e.g., diazepam,
warfarin, phenytoin,
cyclosporine,
disulfiram,
benzodiazepines):
PRILOSEC can
prolong their
elimination. Monitor
and determine need
for dose adjustments
(7.3) • Patients treated
with proton pump
inhibitors and warfarin
may need to be
monitored for
increases in INR and
prothrombin time (7.3)
• Combined inhibitor of
CYP 2C19 and 3A4
(e.g. voriconazole)
may raise omeprazole
levels (7.3) •
Tacrolimus:
PRILOSEC may
increase serum levels
of tacrolimus (7.4) •
Methotrexate:
 PRILOSEC may
increase serum levels
of methotrexate

DR ACTI INDIC CONTRAINDICATION ADVE INTERAC NURS

UG ON ATIO RSE TIONS ING
NA NS REAC IMPLE
ME TION MENT
ATIO
N

Ge . Manag Contraindicated in: Hypersensitivity; Anuria; Acute renal insufficiency; Significant renal impairment (CCr CNS: . Drug- Asses
neri Caus ement dizzin Drug: Use s
c es of 30 mL/min); SCr 2.5 m g/dL (for patients with heart failure); Hyperkalemia; Addison’s disease; Concurrent use ess, with patient
Na loss primar of eplerenone. clumsi eplerenon for
me: of y ness, eqrisk of skin
sodiu hypera heada hyperkale rash
Spir
m ldoster che, mia; freque
olac
bicar onism. sedati concurren ntly
ton
bona Manag on. t use during
e
te ement CV: contraindi therap
Bra and of arrhyt cated. q y.
nd calci edema hmias. hypotensi Discon
Na um associ GI: GI on with tinue
me: while ated irritatio acute diureti
savin with n. GU: ingestion c at
Ald g HF, erectil of alcohol, first
acto potas cirrhos e other sign of
ne sium is and dysfun antihypert rash;
Cla and nephr ction, ensive may
hydr otic dysuri agents, or be life-
ss: ogen syndro a. nitrates. threat
ions me. Endo: Use with ening.
diur
by Manag ameno ACE Steve
etic
anta ement rrhea, inhibitors, ns-
s,
goniz of gynec NSAIDs, Johns
pot
ing essent omasti potassium on
assi
aldos ial a (in suppleme syndro
um-
teron hypert males) nts, me or
spa
e. ension , angiotensi toxic
ring
Ther . breast n II epider
diur
apeu Treat tender receptor mal
etic
tic ment ness, antagonist necrol
s
Effec of deepe s, ysis
ts: hypok ning of potassium may
Incre alemia voice, -sparing develo
ased (count qhair diuretics, p.
survi eracts growth angiotensi Treat
val in potass (in n sympt
patie ium female converting omatic
nts loss s), enzyme ally;
with cause sexual inhibitors, may
sever d by dysfun or recur
e other ction. cyclospori once
heart diureti F and neqrisk of treatm
failur cs). E: hyperkale ent is
e hyperk mia.plithiu stoppe
(New alemia m d.
York , excretion.
PO:
Heart hypon Antihypert
Admini
Asso atremi ensive
ster in
ciatio a, and
AMto
n hyperc diuretic
avoid
class hlorem effectiven
interru
II-IV). ic ess may
Wea metab bepby pting
k olic NSAIDs. sleep
diure acidos Mayqthe patter
tic is. effects of n. ●
and Hemat digoxin.ph Admini
antih : ypoprothr ster
ypert agran ombinemi with
ensiv ulocyt c effect food
e osis, oforal or milk
resp throm anticoagul to
onse bocyto ants. minimi
when penia. Cholestyr ze
comp Derm: aminemay gastric
ared DRUG qrisk of irritatio
with RASH hyperkale n and
other WITH mic to
diure EOSI metabolic increa
tics. NOPH acidosis. se
Cons ILIA bioava
ervati AND ilability
on of SYST .
potas EMIC
●
sium SYMP
Advise
TOMS
patient
(DRE
to
SS),
notify
STEV
health
ENS-
care
JOHN
profes
SON
sional
SYND
if rash,
ROME
muscl
,
e
TOXIC
 EPIDE weakn
RMAL ess or
NECR cramp
OLYSI s;
S, fatigue
alopec ; or
ia, severe
pruritis nause
.MS:m a,
uscle vomiti
cramp ng, or
s.Misc diarrh
:allergi ea
c occurs
reactio .
ns.

DRU ACTI INDI CONTRAINDICATION ADVER INTE NURSI

G ON CAT SE RAC NG
NAM ION REACTI TION IMPLE
E S ON S MENT
ATION
Gen . Trea Contraindicated in: Hypersensitivity to cephalosporins; Serious hypersensitivity to penicillins; Pedi: Neonates CNS: . ●
eric Binds tmen SEIZUR Drug- Obser
Nam to the t of: 28 days (use in hyperbilirubinemic neonates may lead to kernicterus); Pedi: Neonates ES (high Drug: ve
e: bacte Skin doses). Shoul patient
rial and 28 days requiring calcium-containingIV solutions (qrisk of precipitation formation). GI: d not for
Ceftri
cell skin PSEUD be signs
axon
wall struc OMEMB admi and
e
mem ture RANOU nister sympt
Bran brane infec S ed oms of
d , tions COLITIS conc anaph
Nam causi , , omita ylaxis
e: ng Bon diarrhea, ntly (rash,
cell e cholelithi with pruritu
Roce death and asis, any s,
phin . joint gallbladd calciu laryng
Clas Thera infec er m- eal
s: peutic tions sludging. conta edema
Effect , Derm: ining ,
:anti- s: Com rashes, soluti wheezi
infect Bacte plica urticaria. ons. ng).
ives ricidal ted Hemat: Discon
Phar action and bleeding tinue
mac again unco , the
ologi st mpli eosinop drug
c: susce cate hilia, and
third- ptible d hemolyti notify
gene bacte urina c health
ratio ria. ry anemia, care
n Spect tract leukope profes
ceph rum:S infec nia, sional
alosp imilar tions thrombo immed
orins to , cytosis. iately if
that Unc Local: these
of ompl pain at sympt
secon icate IM site, oms
d- d phlebitis occur.
gener gyne atIV Keep
ation colo site.Misc epinep
ceph gical :allergic hrine,
alosp infec reaction an
orins, tions s antihist
but inclu including amine,
activit ding ANAPH and
y gono YLAXIS, resusci
again rrhe superinf tation
st a, ection equip
staph Low ment
yloco er close
cci is respi by in
less, rator the
while y event
activit tract of an
y infec anaph
again tions ylactic
st , reactio
gram- Intra n. ●
negat - Monito
ive abdo r
patho mina bowel
gens l functio
is infec n.
great tions Diarrh
er, , ea,
even Septi abdom
for cemi inal
organ a, crampi
isms Meni ng,
resist ngiti fever,
ant to s, and
first- Otitis bloody
and medi stools
secon a. should
d- Peri be
gener oper reporte
ation ative d to
agent prop health
s. hyla care
xis profes
sional
prompt
ly as a
sign of
pseud
omem
branou
s
colitis.
May
begin
up to
severa
l
weeks
followi
ng
cessati
on of
therap
y
Do not
confus
e
ceftria
xone
with
cefazol
in,
cefoxiti
n,
cefotet
an, or
ceftazi
dime.
●
Instruc
t
patient
to
notify
health
care
profes
sional
if fever
and
diarrhe
a
develo
p,
especi
ally if
diarrhe
a
contai
ns
blood,
 mucus
, or
pus.
Advise
patient
not to
treat
diarrhe
a
without
consult
ing
health
care
profes
sional.

DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE REACTION INTERACTIONS NURSING

IMPLEMENTATION
Generic Name: . Inhibits Treatment of Contraindicated in: CNS: dizziness, seizures, . Drug-Drug: Quinidine, Observe for signs and
protein the following Hypersensitivity to drowsiness, fatigue, procainamide, symptoms of anaphylaxis
Azithromycin
synthesis at infections due azithromycin, headache. CV: dofetilide,sotalol, and (rash, pruritus, laryngeal
Brand Name: the level of the to susceptible erythromycin, or TORSADES DE amiodarone mayqrisk of edema, wheezing). Notify
50S bacterial organisms: othermacrolide anti- POINTES, chest pain, QT interval health care professional
Zithromax, Zmax ribosome. Upper infectives; History of hypotension, palpitations, prolongation; concurrent immediately if these
Class: Therapeutic respiratory cholestatic jaundice or QT interval prolongation. use should be avoided. occur. ● Assess patient
Effects: tract infections, hepatic dysfunction with GI: HEPATOTOXICITY, Aluminum- and for skin rash frequently
macrolides Bacteriostatic including prior use of PSEUDOMEMBRANOUS magnesium-containing during therapy.
action against streptococcal azithromycin.; QT COLITIS, abdominal pain, antacidsppeak levels. Discontinue azithromycin
susceptible pharyngitis, interval prolongation, diarrhea, nausea, Nelfinavirqlevels at first sign of rash; may
bacteria. acute bacterial hypokalemia, cholestatic jaundice, qliver (monitor carefully); be life-threatening.
Spectrum: exacerbations hypomagnesemia, or enzymes, dyspepsia, azithromycin Stevens-Johnson
Active against of chronic bradycardia.; flatulence, melena, oral alsopnelfinavir levels. syndrome or toxic
the following bronchitis and Concurrent use of candidiasis, pyloric Efavirenzqlevels. Mayq epidermal necrolysis may
gram-positive tonsillitis, quinidine, procainamide, stenosis. GU: nephritis, the effects and risk of develop. Treat
aerobic Lower dofetilide, amiodarone, vaginitis. Hemat: anemia, toxicity of warfarin and symptomatically; may
bacteria respiratory or sotalol leukopenia, zidovudine. Other recur once treatment is
tract infections, thrombocytopenia. Derm: macrolide anti stopped. ● Lab Test
including STEVENS-JOHNSON Considerations: May
nfectives have been
bronchitis and SYNDROME, TOXIC causeqserum bilirubin,
known toqlevels and
pneumonia, EPIDERMAL AST, ALT, LDH, and
effects of digoxin,
Acute otitis NECROLYSIS, alkaline phosphatase
theophylline,
media, Skin photosensitivity, rash. concentrations.
ergotamine,
and skin EENT: ototoxicity. F and
dihydroergotamine, PO: Administer 1 hr
structure E: hyperkalemia.Misc:
triazolam, before or 2 hr after meals.
infections, ANGIOEDEMA
carbamazepine,
Nongonococcal Advise patient to report
cyclosporine,
urethritis, symptoms of chest pain,
tacrolimus, and
cervicitis, palpitations, yellowing of
phenytoin; careful
gonorrhea, and skin or eyes, or signs of
monitoring of concurrent
chancroid. superinfection (black,
use is recommended.
furry overgrowth on the
tongue; vaginal itching or
discharge; loose or foul-
smelling stools) or rash. ●
Instruct patient to notify
health care professional if
fever and diarrhea
develop, especially if stool
contains blood, pus, or
mucus. Advise patient not
to treat diarrhea without
advice of health care
professional.
DRUG NAME ACTION INDICATIONS CONTRAINDICATIO ADVERSE INTERACTIONS NURSING
N REACTION IMPLEMENTATIO
N

Generic . Inhibits 3-hydroxy-3- Adjunctive Contraindicated in: . Drug-Drug: If patient develops

Name: methylglutaryl- management of Hypersensitivity; Antacidspabsorption muscle tenderness
CNS: amnesia,
coenzyme A (HMG- primary Active liver disease or (administer 2 hr after during therapy, CK
Rosuvastatin confusion, memory
CoA) reductase, an hypercholesterolemia unexplained rosuvastatin).qrisk of levels should be
loss, weakness. GI:
Brand Name: enzyme which is and mixed persistent elevations myopathy when used with monitored. If CK
abdominal pain,
responsible for dyslipidemias. in AST & ALT;OB, cyclosporine, levels are
Crestor constipation, drug-
catalyzing an early Adjunctive Lactation: Pregnancy lopinavir/ritonavir, markedlyqor
induced
Class: step in the synthesis management of or lactation. Use atazanavir/ritonavir,colchicin myopathy occurs,
hepatitis,qliver
of hypertriglyceridemia. Cautiously in: History e, fibrates or large doses of discontinue
lipid-lowering function tests,
cholesterol.Therapeuti Adjunctive of liver disease; niacin; concurrent use of therapy.
agents nausea. Derm: rash.
c Effects: Lowering of management of Alcoholism; Renal gemfibrozil should be
Pharmacologic Endo: Instruct patient to
total and LDL primary impairment; Patients avoided, if possible;
: HMG-CoA hyperglycemia. notify health care
cholesterol and dysbetalipoproteinemi with Asian ancestry usepdoses with
reductase Hemat: professional if
triglycerides. Slightly a. Homozygous (may haveqblood cyclosporine,
inhibitors thrombocytopenia. unexplained
increases HDL familial levels andqrisk of lopinavir/ritonavir, and
(statins) Metab: muscle pain,
cholesterol. Slows the hypercholesterolemia. rhabdomyolysis) atazanavir/ritonavir.qlevels
RHABDOMYOLYSI tenderness, or
progression of Slows the progression of norgestrel and ethinyl
S, immune-mediated weakness occurs,
coronary of atherosclerosis as estradiol. Mayqrisk of
necrotizing especially if
atherosclerosis. adjunct to diet. bleeding withwarfarin;
myopathy, myalgia. accompanied by
Adjunctive therapy to monitor INR.
fever or malaise.
diet and exercise for
the reduction of LDL
cholesterol in children
DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE REACTION INTERACTIONS NURSING
IMPLEMENTATION

Generic Name: . Increases Treatment of Contraindicated in: . Drug-Drug: Should not be Assess patient for
water content chronic Patients on low- used with other laxatives in abdominal distention,
Lactulose GI: belching, cramps,
and softens constipation. galactose diets. Use the treatment of hepatic presence of bowel
distention, flatulence,
Brand Name: the stool. Adjunct in the Cautiously in: Diabetes encephalopathy (leads to sounds, and normal
diarrhea. Endo:
Lowers the pH management of mellitus; Excessive or inability to determine pattern of bowel function.
Cholac, Constilac, hyperglycemia (diabetic
of the colon, portal-systemic prolonged use (may optimal dose of lactulose). ● Assess color,
Constulose, patients).
which inhibits (hepatic) lead to Anti- consistency, and amount
Enulose, the diffusion of encephalopathy dependence);OB, infectivesmaypeffectiveness of stool produced
Generlac, ammonia from (PSE). Lactation:Safety not in treatment of hepatic
Kristalose PO:Mix with fruit juice,
the colon into established. encephalopathy.
water, milk, or
Class: the blood,
carbonated citrus
thereby
: laxatives beverage to improve
reducing blood
Pharmacologic: flavor. Administer with a
ammonia
osmotics full glass (240 mL) of
levels.
water or juice. May be
Therapeutic
administered on an
Effects: Relief
empty stomach for more
of
rapid results.
constipation.
Decreased Encourage patients to
blood use other forms of bowel
ammonia regulation, such as
levels with increasing bulk in the
improved diet, increasing fluid
mental status intake, and increasing
in PSE. mobility. Normal bowel
habits are individualized
and may vary from 3
times/day to 3 times/wk.
● Caution patients that
this medication may
 cause belching,
flatulence, or abdominal
cramping. Health care
professional should be
notified if this becomes
bothersome or if diarrhea
occurs

DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE REACTION INTERACTIONS NURSING

IMPLEMENTATION

Generic Name: . .

Brand Name:

Class:
DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE REACTION INTERACTIONS NURSING
IMPLEMENTATION

Generic Name: . .

Brand Name:

Class:
DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE REACTION INTERACTIONS NURSING
IMPLEMENTATION

Generic Name: . .

Brand Name:

Class:
DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE REACTION INTERACTIONS NURSING
IMPLEMENTATION

Generic Name: . .

Brand Name:

Class:
DRUG NAME ACTION INDICATIONS CONTRAINDICATION ADVERSE REACTION INTERACTIONS NURSING
IMPLEMENTATION

Generic Name: . .

Brand Name:

Class: